Works by Zelaya, Adelyn


Results: 3
    1
    2

    Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR.

    Published in:
    Journal of Neuro-Oncology, 2021, v. 152, n. 2, p. 233, doi. 10.1007/s11060-021-03703-z
    By:
    • Vaidya, Kedar S.;
    • Mitten, Michael J.;
    • Zelaya-Lazo, Adelyn L.;
    • Oleksijew, Anatol;
    • Alvey, Cory;
    • Falls, Hugh D.;
    • Mishra, Sasmita;
    • Palma, Joann;
    • Ansell, Peter;
    • Phillips, Andrew C.;
    • Reilly, Edward B.;
    • Anderson, Mark;
    • Boghaert, Erwin R.
    Publication type:
    Article
    3